Citation
- Authors: Kang, G. J., Lee, H. J., Byun, H. J., Kim, E. J., Kim, H. J., Park, M. K., Lee, C. H.
- Year: 2017
- Journal: Biochim Biophys Acta 1864 625-633
- Applications: in vitro / DNA / jetPEI
- Cell types:
- Name: THP-1
Description: Human acute monocytic leukaemia cells
Known as: THP1, THP 1 - Name: MDA-MB-231
Description: Human breast adenocarcinoma cells
Known as: MDAMB231
- Name: THP-1
Method
A ratio 1:2 was used for transfection.
Abstract
Resolution of inflammation is important for physiological homeostasis. Chronic inflammatory diseases may be caused by abnormal resolution of inflammation. However, what causes a failure of inflammatory resolution is unclear. Here we investigated the involvement of high mobility group box 1 (HMGB1) protein in the control of inflammatory resolution as an 'anti-resolution factor'. We first confirmed the increased expression of HMGB1 and prostaglandin reductase 1 (PTGR1) in inflammatory conditions and HMGB1-mediated regulation of the expression of PTGR1. The inhibition of phagocytosis by HMGB1 was abrogated by PTGR1 silencing. PTGR1 was a direct target of miR522-3p and its expression was regulated by miRNA-522-3p inhibitor or mimic. Finally, miR-522-3p had an important role in the regulation of PTGR1 expression by HMGB1. The data indicates that HMGB1-miR-522-3p-PTGR1 axis may be involved in the abnormal resolution of inflammation and suggests that this mechanism might be a target for modulation of chronic inflammatory disorder.